Future research focusing on this pathway’s effects on key EMT transcription factors and biomarkers (such as E-cadherin, N-cadherin, and vimentin) will be crucial for comprehensively elucidating its role in bladder cancer dissemination. The gene discussed is CDH2; the disease is urinary bladder cancer.